The dual PI3K/mTORC1/C2 inhibitors NVP-BGT226 and NVP-BEZ235 dose-dependently inhibited proliferation and induced cell death in all ALL-LTCs (Figure 5A and 5B). Here, PIK3CA is linked to acute lymphoblastic leukemia.